Liposuction, breast augmentation and Botox use up in US
[WASHINGTON] The number of surgical or minimally invasive cosmetic procedures are up in the United States, but trends are changing towards scalpel-free techniques such as the use of Botox, according to figures out Monday.
There were more than 17.7 million such procedures in 2018, according to figures from the American Society of Plastic Surgeons (ASPS).
Long-term trends show that the number of cosmetic surgical operations are down -- a decrease of five percent from 2018 compared to 2000. There were around 1.8 million last year, 100,000 fewer than at the turn of the century.
Cosmetic nose, chin, ear, eyelids and forehead procedures have lost some popularity.
Liposuctions are also less popular, but remain much used (258,000 operations in 2018), and has seen a revival in recent years, with a five percent annual increase in each of the last two years.
Breast augmentations are still the most popular plastic surgery operation, with more than 300,000 each year and a four percent increase last year.
But in total there is almost ten times more minimally-invasive interventions than surgical operations: 15.9 million last year, a two percent growth over the previous year.
The most common procedure by far is an injection of the Botulinum toxin to hide wrinkles, with 7.4 million such procedures in 2018.
Also popular: soft tissue fillers like lip plumping with hyaluronic acid injections, with 2.68 million such procedures.
These figures are reported by the 8,000 certified physicians and members of the Society, and do not include data on complications or incidents related to these interventions.
AFP
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Shein steps up London IPO preparations amid US hurdles to listing, sources say
US bill to restrict WuXi AppTec, Chinese biotechs revised to give more time to cut ties
New weight-loss, diabetes drugs reach one in eight Americans
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife says private placement is to address urgent cash needs
Cordlife substantial shareholders lay out separate plans to address issues after AGM